{"id":"W2088569180","doi":"10.1038/jid.2012.163","title":"Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial","year":2012,"lang":"en","type":"letter","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":143,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"Amgen","keywords":"Psoriasis; Medicine; Placebo; Randomized controlled trial; Antibody response; Clinical trial; Internal medicine; Pharmacology; Antibody; Immunology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.005687262,0.001285714,0.008262978,0.001649953,0.000229209,0.00007506381,0.0009287783,0.003050933,0.0002793045],"category_scores_gemma":[0.009006888,0.0008302137,0.001239281,0.000598587,0.001151894,0.0003458508,0.0001609805,0.003732167,0.0004783669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002582181,"about_ca_system_score_gemma":0.00179442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007593936,"about_ca_topic_score_gemma":0.00004218932,"domain_scores_codex":[0.9708838,0.02172032,0.004667781,0.001088044,0.000308715,0.00133128],"domain_scores_gemma":[0.9799585,0.01431554,0.003832522,0.0008096004,0.0007108483,0.0003730412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6853742,0.000597265,0.00006080074,0.00001744983,0.003889926,0.001753365,0.00194206,0.00002196395,0.01241928,0.000003891552,0.2936611,0.0002587268],"study_design_scores_gemma":[0.8956124,0.004181361,0.0001452289,0.0006319926,0.002121464,0.001320637,0.0001629551,0.000003631442,0.02816942,0.00008451237,0.06665503,0.0009113859],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8112722,0.001477788,0.00009090399,0.1767987,0.004656054,0.004422008,0.001136334,0.00004293428,0.0001030886],"genre_scores_gemma":[0.7428564,0.0009473508,0.005343082,0.2360267,0.006909023,0.001213319,0.003344625,0.0003595755,0.00299986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.227006,"threshold_uncertainty_score":0.9999894,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03603419821464761,"score_gpt":0.3114115448352607,"score_spread":0.2753773466206131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}